Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials

Two new clinical trials presented by Calpis Co., Ltd. at the American Society of Hypertension Twenty-Third Annual Scientific Meeting and Exposition in New Orleans show that the milk-derived dietary supplement AmealPeptide reduces blood pressure in hypertensive patients.